Press release
Projecting the Global Diabetes Care Devices Market Size to Expand at a 7.26% CAGR Through 2034, DelveInsight Analysis
As per DelveInsight's assessment, The diabetes care devices market is largely driven by the increasing global burden of diabetes, supported by rising obesity levels, sedentary habits, and an aging population. Additionally, greater awareness regarding early detection and the need for continuous glucose monitoring is accelerating the adoption of advanced technologies, including continuous glucose monitors (CGMs), insulin pumps, and smart insulin pens.
DelveInsight's "Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Diabetes Care Devices companies actively working in the market.
Explore the future of healthcare innovation with our comprehensive Diabetes Care Devices Market Forecast. Stay ahead in the industry!
https://www.delveinsight.com/report-store/diabetes-care-devices-market [https://www.delveinsight.com/report-store/diabetes-care-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Diabetes Care Devices Overview
Diabetes Care Devices are medical tools designed to help individuals with diabetes monitor and manage their blood glucose levels effectively. These devices play a crucial role in improving disease control, preventing complications, and supporting daily diabetes management.
Common types of diabetes care devices include blood glucose monitoring systems (BGMS), continuous glucose monitoring (CGM) devices, insulin pumps, insulin pens, and smart insulin delivery systems. Blood glucose meters allow patients to measure glucose levels using a small blood sample, while CGM devices provide real-time glucose readings throughout the day. Insulin pumps and smart pens help deliver accurate insulin doses, improving glycemic control and patient convenience.
Diabetes Care Devices Market Insights
The diabetes care devices market is mainly driven by the growing global prevalence of diabetes, largely attributed to rising obesity levels, sedentary lifestyles, unhealthy dietary patterns, and an expanding aging population. As the number of diabetes cases continues to rise, the demand for effective solutions to monitor and manage blood glucose levels is increasing, thereby boosting the adoption of advanced diabetes management devices. Moreover, increasing awareness about early diagnosis, routine monitoring, and maintaining proper glycemic control is encouraging both patients and healthcare professionals to utilize technologies such as continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens.
DelveInsight Analysis: The global diabetes care devices market size is projected to grow from USD 40,781.76 million in 2025 toUSD 76,404.07 million by 2034, indicating robust and sustained expansion. During the 2026-2034 forecast period, the market is anticipated to register a compound annual growth rate (CAGR) of 7.26%.
To know more about why North America is leading the market growth in the Diabetes Care Devices market, get a snapshot of the report Diabetes Care Devices Market Trends [https://www.delveinsight.com/sample-request/diabetes-care-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Recent Developments in the Diabetes Care Devices Market Report
*
In August 2025, Signos launched the Signos Glucose Monitoring System, the first FDA-cleared, over-the-counter glucose monitoring system designed for weight management. The system integrates the Stelo by Dexcom glucose biosensor with an AI-powered platform, providing personalized, real-time insights into how food, activity, stress, and sleep impact metabolic health.
*
In July 2025, Medtronic plc. announced that it had received CE Mark in Europe to expand indications of the MiniMed Trademark 780G system for individuals aged 2 years and older, during pregnancy, and for those with type 2 insulin-requiring diabetes.
*
In May 2025, GO-Pen ApS received FDA 510(k) clearance for the GO-PEN Registered , a user-filled insulin pen compatible with standard insulin vials, providing an affordable alternative to traditional disposable pens.
*
In April 2025, Dexcom received FDA clearance for the G7 15-Day sensor, which boasts extended wear time and enhanced accuracy for diabetes management.
*
In September 2024, the Eversense 365 received FDA clearance as an integrated continuous glucose monitoring (iCGM) system for individuals with diabetes. Unlike short-term CGMs that typically last 10 to 14 days, the Eversense 365 features a single sensor that can be used for an entire year, offering minimal disruption to daily life.
*
In August 2024, Medtronic plc., a global leader in healthcare technology, announced that the U.S. FDA had approved its Simplera Trademark continuous glucose monitor (CGM), the company's first disposable, all-in-one CGM. The device was half the size of previous Medtronic CGMs, with a discreet design that simplified insertion and wear, eliminating the need for overtape.
*
In May 2024, Smart Meter launched iGlucose Plus for diabetes management, a cellular-enabled glucose meter that eliminated the need for syncing, pairing, or relying on smartphones and Wi-Fi.
Key Players in the Diabetes Care Devices Market
Some of the key market players operating in the Diabetes Care Devices market include- Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo Corporation, CeQur, EOFLOW CO., LTD, Sanofi, Medtronic, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, and others.
To read more about the latest highlights related to Diabetes Care Devices, get a snapshot of the key highlights entailed in the Diabetes Care Devices Market Forecast Report [https://www.delveinsight.com/sample-request/diabetes-care-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Market Analysis on the Diabetes Care Devices Market
According to estimates, North America is expected to hold the largest share of around 41% of the global diabetes care devices market in 2025, driven by the high incidence of diabetes, well-established healthcare infrastructure, and the widespread use of advanced technologies such as continuous glucose monitoring (CGM) systems and insulin pumps. The region also benefits from supportive reimbursement policies, significant healthcare spending, and the strong presence of major industry players, which encourage innovation and faster product adoption. Furthermore, growing awareness regarding early diagnosis and effective disease management continues to boost the demand for diabetes care devices across the region.
The diabetes care devices market features a competitive landscape shaped by the presence of established global companies along with emerging technology innovators, creating a moderately concentrated yet highly dynamic market. Leading players are placing greater emphasis on product innovation, strategic collaborations, and expanding their geographic reach to strengthen their market position. This has led to the frequent introduction of advanced technologies such as continuous glucose monitoring (CGM) systems, smart insulin delivery devices, and digitally connected diabetes management solutions.
Scope of the Diabetes Care Devices Market Report
*
Coverage: Global
*
Study Period: 2023-2034
*
Diabetes Care Devices Market Segmentation By Product Type: Blood Glucose Monitoring Devices {Wearable and Non Wearable
*
Diabetes Care Devices Market Segmentation By Insulin Delivery Devices: Insulin Syringes, Insulin Pens, Insulin Pumps, and Others} and Integrated Systems),
*
Diabetes Care Devices Market Segmentation By Monitoring Devices: Self-Monitoring and Continuous Monitoring
*
Diabetes Care Devices Market Segmentation By Patient Type: Type 1, Type 2, and Gestational Diabetes
*
Diabetes Care Devices Market Segmentation By End Users: Hospitals & Clinics, Homecare Settings, and others
*
Diabetes Care Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
*
Key Diabetes Care Devices Companies: Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo Corporation, CeQur, EOFLOW CO., LTD, Sanofi, Medtronic, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, and others
*
Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the Diabetes Care Devices market are set to emerge as the trendsetter explore @ Diabetes Care Devices Manufacturer [https://www.delveinsight.com/sample-request/diabetes-care-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1
Diabetes Care Devices Market Report Introduction
2
Diabetes Care Devices Market Executive summary
3
Regulatory and Patent Analysis
4
Diabetes Care Devices Market Key Factors Analysis
5
Porter's Five Forces Analysis
6
COVID-19 Impact Analysis on Diabetes Care Devices Market
7
Diabetes Care Devices Market Layout
8
Global Company Share Analysis - Key 3-5 Companies
9
Company and Product Profiles
10
Diabetes Care Devices Market Drivers
11.
Diabetes Care Devices Market Barriers
12.
Project Approach
13.
About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=projecting-the-global-diabetes-care-devices-market-size-to-expand-at-a-726-cagr-through-2034-delveinsight-analysis]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Projecting the Global Diabetes Care Devices Market Size to Expand at a 7.26% CAGR Through 2034, DelveInsight Analysis here
News-ID: 4428687 • Views: …
More Releases from ABNewswire
Acute Kidney Injury Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Kidney Injury pipeline constitutes 30+ key companies continuously working towards developing 30+ Acute Kidney Injury treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Acute Kidney Injury Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also…
Duchenne Muscular Dystrophy Clinical Pipeline Accelerates: Over 75 Companies Adv …
Duchenne Muscular Dystrophy Companies include Santhera Pharmaceuticals, Sarepta Therapeutics, Italfarmaco, Wave Life Sciences Ltd, FibroGen, EDG 5506 Edgewise Therapeutics, Fordadistrogene movaparvovec, Daiichi Sankyo, Sarepta Therapeutics, Inc., ENCell, Taiho Pharmaceutical, Solid Biosciences, Capricor, Nippon Shinyaku, Hansa Biopharma, and others.
Duchenne Muscular Dystrophy Companies include Santhera Pharmaceuticals, Sarepta Therapeutics, Italfarmaco, Wave Life Sciences Ltd, FibroGen, EDG 5506 Edgewise Therapeutics, Fordadistrogene movaparvovec, Daiichi Sankyo, Sarepta Therapeutics, Inc., ENCell, Taiho Pharmaceutical, Solid Biosciences, Capricor, Nippon…
IZERVAY Market to Witness Robust Growth Through 2034 Driven by Rising Geographic …
IZERVAY sales market forecast report provides a detailed market assessment of IZERVAY for approved indication like Dry age-related macular degeneration; as well as potential inidcations like Polypoidal choroidal vasculopathy; and Wet age-related macular degeneration in the 7MM.
DelveInsight's latest report, "IZERVAY Sales Forecast, and Market Size Analysis - 2034," provides a comprehensive evaluation of the evolving IZERVAY market, highlighting strong growth potential driven by increasing adoption, expanding treatment volumes, and continued…
Ablation Devices Market to Reach USD 15.34 Billion by 2034, Growing at a CAGR of …
Ablation Devices companies include Medtronic, Boston Scientific Corporation, Abbott, Johnson & Johnson Services Inc, AtriCure, Inc., Stryker, Smith & Nephew, Hologic, Inc., CONMED Corporation., Biotronik SE & Co. KG, AngioDynamics, Inc., BD, Terumo Corporation, Merit Medical Systems, Inc., Olympus Corporation, Karl Storz GmbH & Co. KG, Varian Medical Systems Inc, Integra LifeSciences, Japan Lifeline Co Ltd, Avanos Medical, Inc., and others.
DelveInsight's latest market intelligence report highlights that the global Ablation…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027.
Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
